Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - 9 days ago Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready? - 19 days ago On the front lines of the superbug war, new treatments can’t arrive soon enough - about 2 months ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program - 11 days ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - about 2 months ago STAT+: To mitigate drug shortages, a new study suggests looking at Canada - about 2 months ago STAT+: Pharmalittle: We’re reading about FDA oversight of shortages, AstraZeneca threats, and more - 2 months ago STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 2 months ago STAT+: Sales from controversial drug discount program rose to $63 billion last year - 2 months ago STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more - 9 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 9 months ago STAT+: Pharmalittle: We’re reading about a White House drug-shortage plan, a Genmab deal, and more - 9 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 9 months ago STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more - 10 months ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - 10 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 10 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 10 months ago STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived - 10 months ago STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages - 11 months ago STAT+: Pharmalittle: We’re reading about FDA’s syphillis-drug plan, India’s manufacturer-inspection demands, and more - 12 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 12 months ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - 12 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - about 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - about 1 year ago STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies - about 1 year ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - about 1 year ago STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment - about 1 year ago STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages - about 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - about 1 year ago STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - about 1 year ago STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - over 1 year ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - over 1 year ago
3	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Drugmaker shut down after black schmutz found in injectable weight-loss drug - about 2 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Survey: 50% of Active Drug Shortages in the United States Persist for 2 or More Years - about 2 months ago Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide - 2 months ago FDA Adds Intravenous Fluids to List of Drug Shortages - 2 months ago Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages - over 1 year ago
5	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 2 months ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 2 months ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 2 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - 9 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - 10 months ago
8	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Lawmakers Pan DEA's Leaked Plans for Telehealth - 2 months ago Medical Schools Push Back on 'March-In' Rights Plan to Lower Drug Prices - 11 months ago Experts, Lawmakers Explore Downside of Drug-Price Negotiation - about 1 year ago Experts, Senators Wrestle Over Thorny Drug Shortage Challenge - about 1 year ago
9	Susanna Vogel Healthcare Dive Currently at Healthcare Dive. Seen in various outlets. Greenpoint healthcarejournalism	CVS Health slashes infusion services offerings, blaming industry headwinds - 2 months ago
10	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays - 4 months ago

Journalists covering drug shortages